Babik Barna, Fazakas János, Matusovits Andrea, Fülesdi Béla
Aneszteziológiai és Intenzív Terápiás Intézet, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Semmelweis u. 6., 6720.
Transzplantációs és Sebészeti Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest.
Orv Hetil. 2019 Feb;160(6):203-213. doi: 10.1556/650.2019.31317.
Severe perioperative bleeding increases perioperative morbidity and mortality. The management of the consequences imposes high burden on the human and financial resources of healthcare providers. Since 2009, there has been a continued worldwide decline in demand for allogenic blood products. This tendency can mainly be attributed to Perioperative Blood Management Program and to new innovative management applying haemostatic factor concentrates, viscoelastic assays and guidelines for treatment of the severe periprocedural bleeding patients. One of the major challenges of our times is still to match blood supply with demand. The new diagnostic and therapeutic modalities for managing the bleeding patients require new financial resources on the one hand and, on the other hand, call for redistribution of the material means provided by the health care system. Achieving interoperability between financial resources allocated to allogenic blood products and factor concentrates, the current state-of-the-art approach for managing the bleeding patient can be used to save blood and the lives of patients simultaneously. Orv Hetil. 2019; 160(6): 203-213.
围手术期严重出血会增加围手术期的发病率和死亡率。对其后果的处理给医疗服务提供者的人力和财力资源带来了沉重负担。自2009年以来，全球对同种异体血制品的需求持续下降。这种趋势主要归因于围手术期血液管理计划以及应用止血因子浓缩物、粘弹性检测和治疗严重围手术期出血患者指南的新型创新管理方法。我们这个时代的主要挑战之一仍然是使血液供应与需求相匹配。管理出血患者的新诊断和治疗方式一方面需要新的财政资源，另一方面需要对医疗保健系统提供的物质手段进行重新分配。实现分配给同种异体血制品和因子浓缩物的财政资源之间的互操作性，当前管理出血患者的最先进方法可用于同时节省血液和挽救患者生命。《匈牙利医学周报》。2019年；160(6):203 - 213。
